Xcout Intel
Broadwing Bio competitors & alternatives
The 12 closest competitors and alternatives to Broadwing Bio among biotechnology companies — ranked by similarity to what Broadwing Bio actually does, not by market-cap band.
Subscribe to see Broadwing Bio’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Broadwing Bio
Broadwing Bio is a biotechnology company that develops antibody-based therapies to treat major causes of adult vision loss, specifically focusing on Geographic Atrophy and Glaucoma. The company utilizes genetics-driven insights to target ocular diseases and preserve vision for patients.
Broadwing Bio at a glance
Broadwing Bio is a biotechnology company. Its most recent funding round, Convertible Debt, raised $10M in December 2020. Xcout tracks 5 named people at Broadwing Bio, including Andrew Peterson (Founder, CEO and board member).
Broadwing Bio leadership
- Andrew PetersonFounder, CEO and board member
- Jennifer CyganFounder
- Manuel RivasFounder and scientific advisory board member
- Errik AndersonBoard member and CEO of Alloy Therapeutics
- Atul DandekarBroadwing board member and chief strategy officer at Maze Therapeutics
Broadwing Bio funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Convertible Debt | $10M | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Broadwing Bio competitors
Ranked by semantic similarity — how close each company is to Broadwing Bio by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
Character Biosciences is a biotechnology company that uses human genetics and functional genomics to discover and develop precision medicines. Its work has focused particularly on genetically informed therapies for age-related diseases, including ophthalmic conditions such as age-related macular degeneration.
Similar biotechnology company
Beacon Therapeutics is a clinical-stage biotechnology company dedicated to saving and restoring sight for people living with rare and prevalent ocular diseases. The company works to deliver advanced retinal gene therapies to patients experiencing blindness.
Similar biotechnology company
Graybug Vision, Inc. is a clinical-stage biopharmaceutical company headquartered in Redwood City, California, with additional offices in Baltimore, Maryland, focused on developing medicines for ocular diseases.
Similar biotechnology company
Tavo Biotherapeutics is a biotechnology company headquartered in Laguna Beach, California. The company focuses on driving breakthrough pharmaceutical innovations and developing novel treatments for glaucoma and vision preservation.
Similar biotechnology company
SparingVision is a genomic and gene therapy medicines company translating pioneering science into vision-saving treatments, with US headquarters located in Boston, Massachusetts.
Biotech
Alkeus Pharmaceuticals, Inc. is a late-stage biopharmaceutical company based in Cambridge, Massachusetts, dedicated to developing treatments that preserve the sight of individuals impacted by severe eye diseases.
Similar biotechnology company
Atsena Therapeutics, Inc. is a clinical-stage gene therapy company headquartered in Durham, North Carolina, established in 2019. The firm focuses on developing novel gene therapies to treat debilitating inherited blinding diseases using proprietary vector delivery technologies. Its scientific pipeline aims to address areas of high unmet medical need in ophthalmology.
Biotech
SpliceBio is a clinical-stage genetic medicines company that develops gene therapies using a proprietary Protein Splicing platform. The company focuses on treating diseases caused by mutations in large genes, with a lead clinical program targeting Stargardt disease.
Similar biotechnology company
Tarsier Pharma Ltd. is a late clinical-stage pharmaceutical company that develops bio-inspired medical solutions for autoimmune and inflammatory ocular diseases. The company utilizes a proprietary molecule-derived technology platform to target conditions such as non-infectious uveitis and uveitic glaucoma through eye drops and intravitreal injections.
Similar biotechnology company
Acucela is a biotechnology company developing ophthalmic therapeutics for retinal diseases, including age-related macular degeneration and Stargardt disease. Its research has included visual-cycle modulators such as emixustat, aimed at treating degenerative eye conditions.
Biotech
AAVantgarde Bio is an Italian biotechnology company developing adeno-associated virus (AAV) gene therapies for rare genetic diseases, including conditions caused by genes too large to fit into a single AAV vector. Its technology uses dual-AAV approaches to deliver larger therapeutic genes, serving patients with serious inherited disorders and the clinicians who treat them.
Similar biotechnology company
Memento Medicines, Inc. is a privately held biotechnology company headquartered in Boston, Massachusetts, focused on developing novel biologic therapies for retinal diseases.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Broadwing Bio and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Broadwing Bioand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →